<?xml version="1.0" encoding="UTF-8"?>
<ref id="C166">
 <label>166</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Rabie</surname>
    <given-names>H</given-names>
   </name>, 
   <name name-style="western">
    <surname>Denti</surname>
    <given-names>P</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lee</surname>
    <given-names>J</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Lopinavir–ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir–ritonavir without rifampicin: a pharmacokinetic modelling and clinical study</article-title>. 
  <source>Lancet HIV</source>
  <year>2019</year>; 
  <volume>6</volume>: 
  <fpage>E32</fpage>–
  <lpage>E42</lpage>. doi:
  <pub-id pub-id-type="doi">10.1016/S2352-3018(18)30293-5</pub-id>
 </mixed-citation>
</ref>
